Uberflip is the world’s #1 Content Experience Platform (CEP). With tools to aggregate all your marketing content, they empower B2B marketing and sales teams to create personalized content experiences to engage accounts, nurture prospects, and convert leads, without the help of IT. It’s their mission to put control back in the hands of marketing teams to deliver high-converting experiences, that put the customer front and center.

C-Suite On Deck

Randy Frisch, CMO and Co-Founder at Uberflip has led the content experience movement, prompting marketers to think beyond content creation and focus on the experience. 

Randy also co-hosts the Conex Show, a weekly podcast featuring top marketers and their strategies ...

Events

Related News

BUSINESS INSIGHTS

CAMBREX TO ACQUIRE SNAPDRAGON CHEMISTRY, A LEADER IN CONTINUOUS FLOW API DEVELOPMENT SERVICES

Cambrex | November 22, 2022

news image

Cambrex, a leading global contract development and manufacturing organization providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Snapdragon specializes in active pharmaceutical ingredient batch and continuo...

Read More

BUSINESS INSIGHTS

QUOTIENT SCIENCES ACQUIRES ARCINOVA

Quotient Sciences, Arcinova | February 09, 2021

news image

Quotient Sciences, the drug development and manufacturing accelerator, reported that it has procured Arcinova, the U.K.- based multiservice contract development and manufacturing organization (CDMO). With more than 40 years of involvement and 160 representatives, Arcinova gives drug substance, drug item and bioanalysis administrations to more than 200 pharma and biotech clients around the world. The obtaining expands Quotient's administration portfolio and will empower the inc...

Read More

BUSINESS INSIGHTS

ADARE PHARMA SOLUTIONS ACQUIRES FRONTIDA BIOPHARM TO EXPAND LEADING CDMO OFFERINGS

Adare Pharma Solutions | December 02, 2021

news image

Adare Pharma Solutions ("Adare"), a technology-driven contract development and manufacturing organization (CDMO), announced the acquisition of Frontida BioPharm ("Frontida"), a vertically integrated CDMO focused on oral formulations. The acquisition reinforces Adare's commitment to transform drug delivery by providing world class solutions from product development through commercial scale manufacturing and packaging. Adare's portfolio of offerings for its custom...

Read More

PHARMACY MARKET

AIKIDO PHARMA ANNOUNCES STRATEGIC INTEREST IN ASP ISOTOPES INC.

AIkido Pharma Inc. | December 07, 2021

news image

AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched isotopes. ASP Isotopes' Aerodynamic Separation Process is a method of enriching molybdenum-100 which is a stable isotope of molybdenum. Technetium-99m is the most used radioisotope in the nuclear imaging industry, but the supply chain, which involves the radioactive decay of molybdenum-99 has been fraught with problems dur...

Read More
news image

BUSINESS INSIGHTS

CAMBREX TO ACQUIRE SNAPDRAGON CHEMISTRY, A LEADER IN CONTINUOUS FLOW API DEVELOPMENT SERVICES

Cambrex | November 22, 2022

Cambrex, a leading global contract development and manufacturing organization providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Snapdragon specializes in active pharmaceutical ingredient batch and continuo...

Read More
news image

BUSINESS INSIGHTS

QUOTIENT SCIENCES ACQUIRES ARCINOVA

Quotient Sciences, Arcinova | February 09, 2021

Quotient Sciences, the drug development and manufacturing accelerator, reported that it has procured Arcinova, the U.K.- based multiservice contract development and manufacturing organization (CDMO). With more than 40 years of involvement and 160 representatives, Arcinova gives drug substance, drug item and bioanalysis administrations to more than 200 pharma and biotech clients around the world. The obtaining expands Quotient's administration portfolio and will empower the inc...

Read More
news image

BUSINESS INSIGHTS

ADARE PHARMA SOLUTIONS ACQUIRES FRONTIDA BIOPHARM TO EXPAND LEADING CDMO OFFERINGS

Adare Pharma Solutions | December 02, 2021

Adare Pharma Solutions ("Adare"), a technology-driven contract development and manufacturing organization (CDMO), announced the acquisition of Frontida BioPharm ("Frontida"), a vertically integrated CDMO focused on oral formulations. The acquisition reinforces Adare's commitment to transform drug delivery by providing world class solutions from product development through commercial scale manufacturing and packaging. Adare's portfolio of offerings for its custom...

Read More
news image

PHARMACY MARKET

AIKIDO PHARMA ANNOUNCES STRATEGIC INTEREST IN ASP ISOTOPES INC.

AIkido Pharma Inc. | December 07, 2021

AIkido Pharma Inc. announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched isotopes. ASP Isotopes' Aerodynamic Separation Process is a method of enriching molybdenum-100 which is a stable isotope of molybdenum. Technetium-99m is the most used radioisotope in the nuclear imaging industry, but the supply chain, which involves the radioactive decay of molybdenum-99 has been fraught with problems dur...

Read More